WallStreetZenWallStreetZen

NASDAQ: CRDL
Cardiol Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cardiol Therapeutics earnings were -$26.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CRDL earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$9.4M, up 94.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CRDL reported annual earnings of -$21.1M, with -6.3% growth.

CRDL earnings history

Current Revenue
$0.0
Current Earnings
-$26.6M
Current Profit Margin
0%

CRDL Return on Equity

Current Company
-195.1%
Current Industry
12.8%
Current Market
35%
CRDL's Return on Equity (-195.1%)... subscribe to Premium to read more.
High Return on Equity Performance

CRDL Return on Assets

Current Company
-129.5%
Current Industry
5.8%
CRDL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CRDL announces earnings.

CRDL Return on Capital Employed

Current Company
-342.02%
Current Industry
11.7%
CRDL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRDL vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CRDL-$25.72M-$26.00MN/A-$0.39
CTOR-$20.57M-$21.15MN/A-$0.31
DERM-$12.97M-$18.34MN/A-$0.94
INCRN/A-$17.64MN/A-$0.39
BGM-$6.52M-$7.86MN/A-$1.10
View Top Pharmaceutical Stocks

Cardiol Therapeutics Earnings Reports & History FAQ

What were Cardiol Therapeutics's earnings last quarter?

On CRDL's earnings call on Invalid Date, Cardiol Therapeutics (NASDAQ: CRDL) reported Q3 2024 earnings per share (EPS) of -$0.13, up 97.01% year over year. Total CRDL earnings for the quarter were -$9.36 million. In the same quarter last year, Cardiol Therapeutics's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.

Is Cardiol Therapeutics profitable or losing money?

As of the last Cardiol Therapeutics earnings report, Cardiol Therapeutics is currently losing money. Cardiol Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$26.57 million, a 28.08% increase year over year.

What was CRDL's earnings growth in the past year?

As of Cardiol Therapeutics's earnings date in Invalid Date, Cardiol Therapeutics's earnings has grown year over year. CRDL earnings in the past year totalled -$26.00 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.